G1 Therapeutics, Inc. (G1H.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:02AM CEST
| Previous close | 3.8940 |
| Open | 3.8780 |
| Bid | 3.9620 x 0 |
| Ask | 4.0700 x 0 |
| Day's range | 3.8780 - 3.8780 |
| 52-week range | 1.0350 - 4.4180 |
| Volume | |
| Avg. volume | 799 |
| Market cap | 205.277M |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Shareholders of G1 Therapeutics, Inc. ( NASDAQ:GTHX ) will be pleased this week, given that the stock price is up 13...
- Simply Wall St.
G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
G1 Therapeutics ( NASDAQ:GTHX ) First Quarter 2024 Results Key Financial Results Revenue: US$14.5m (up 12% from 1Q...
- Insider Monkey
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
© 2024 Yahoo. All rights reserved.